WO2003014063A3 - Geschützte 3,5-dihydroxy-2,2-dimethyl-valeroamide für die synthese von epothilonen und derivaten und verfarhen zur herstellung und die verwendung - Google Patents

Geschützte 3,5-dihydroxy-2,2-dimethyl-valeroamide für die synthese von epothilonen und derivaten und verfarhen zur herstellung und die verwendung Download PDF

Info

Publication number
WO2003014063A3
WO2003014063A3 PCT/EP2002/008726 EP0208726W WO03014063A3 WO 2003014063 A3 WO2003014063 A3 WO 2003014063A3 EP 0208726 W EP0208726 W EP 0208726W WO 03014063 A3 WO03014063 A3 WO 03014063A3
Authority
WO
WIPO (PCT)
Prior art keywords
production
derivatives
valeroamides
dihydroxy
dimethyl
Prior art date
Application number
PCT/EP2002/008726
Other languages
English (en)
French (fr)
Other versions
WO2003014063A2 (de
Inventor
Juergen Westermann
Orlin Petrov
Johannes Platzek
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Priority to MXPA04000954A priority Critical patent/MXPA04000954A/es
Priority to EP02774500A priority patent/EP1412322A2/de
Priority to IL16015902A priority patent/IL160159A0/xx
Priority to KR10-2004-7001710A priority patent/KR20040029394A/ko
Priority to JP2003519015A priority patent/JP2004537589A/ja
Priority to BR0211649-9A priority patent/BR0211649A/pt
Priority to CA002456255A priority patent/CA2456255A1/en
Publication of WO2003014063A2 publication Critical patent/WO2003014063A2/de
Publication of WO2003014063A3 publication Critical patent/WO2003014063A3/de
Priority to NO20040912A priority patent/NO20040912L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/08—1,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/16—Preparation of optical isomers
    • C07C231/18—Preparation of optical isomers by stereospecific synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/16—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/002—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by oxidation/reduction reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Die Erfindung betrifft neue geschützte 3,5-Dihydroxy-2,2-dimethyl-valeroamide für die Synthese von Epothilonen und Derivaten und Verfahren zur Herstellung und die Verwendung der neuen Verbindungen zur Herstellung von Epothilonen oder Epothilonderivaten.
PCT/EP2002/008726 2001-08-03 2002-08-05 Geschützte 3,5-dihydroxy-2,2-dimethyl-valeroamide für die synthese von epothilonen und derivaten und verfarhen zur herstellung und die verwendung WO2003014063A2 (de)

Priority Applications (8)

Application Number Priority Date Filing Date Title
MXPA04000954A MXPA04000954A (es) 2001-08-03 2002-08-05 3,5-dibidroxi-2,2-dimetil-valeroamidas protegidas para la sintesis de epotilonas y derivados, un procedimiento para su preparacion y el empleo de las mismas.
EP02774500A EP1412322A2 (de) 2001-08-03 2002-08-05 Geschützte 3,5-dihydroxy-2,2-dimethyl-valeroamide für die synthese von epothilonen und derivaten und verfarhen zur herstellung und die verwendung
IL16015902A IL160159A0 (en) 2001-08-03 2002-08-05 Protected 3,5-dihydroxy-2.2-dimethyl-valeroamides for synthesis of epothilone and derivatives and method for their production and use thereof
KR10-2004-7001710A KR20040029394A (ko) 2001-08-03 2002-08-05 에포틸론 및 유도체의 합성을 위한 보호3,5-디히드록시-2,2-디메틸-발레로아미드 및 그의 제조방법 및 용도
JP2003519015A JP2004537589A (ja) 2001-08-03 2002-08-05 エポチロン及びエポチロン誘導体の合成のための保護された３，５−ジヒドロキシ−２，２−ジメチル−バレロニトリル、その生成方法及び使用
BR0211649-9A BR0211649A (pt) 2001-08-03 2002-08-05 3,5-dihidróxi-2,2-dimetil-valeroamidas protegidas, para a sìntese de epotilonas e derivados e processos para produção e o uso
CA002456255A CA2456255A1 (en) 2001-08-03 2002-08-05 Protected 3.5-dihydroxy-2.2-dimethyl-valeroamides for the synthesis of epothilone and derivatives and method for the production and use thereof
NO20040912A NO20040912L (no) 2001-08-03 2004-03-02 Beskyttede 3,5-dihydroksy-2,2-dimetyl-valeroamider for syntese av epotiloner og derivater derav, og fremgangsmate for fremstilling og andvendelse derav.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10138348.7 2001-08-03
DE10138348A DE10138348A1 (de) 2001-08-03 2001-08-03 Geschützte 3,5-Dihydroxy-2,2-dimethyl-valeroamide für die Synthese von Epothilonen und Derivaten und Verfahren zur Herstellung und die Verwendung

Publications (2)

Publication Number Publication Date
WO2003014063A2 WO2003014063A2 (de) 2003-02-20
WO2003014063A3 true WO2003014063A3 (de) 2003-05-01

Family

ID=7694415

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/008726 WO2003014063A2 (de) 2001-08-03 2002-08-05 Geschützte 3,5-dihydroxy-2,2-dimethyl-valeroamide für die synthese von epothilonen und derivaten und verfarhen zur herstellung und die verwendung

Country Status (16)

Country Link
EP (1) EP1412322A2 (de)
JP (1) JP2004537589A (de)
KR (1) KR20040029394A (de)
CN (2) CN1538952A (de)
AR (1) AR036207A1 (de)
BR (1) BR0211649A (de)
CA (1) CA2456255A1 (de)
DE (1) DE10138348A1 (de)
IL (1) IL160159A0 (de)
MX (1) MXPA04000954A (de)
NO (1) NO20040912L (de)
PE (1) PE20030345A1 (de)
PL (1) PL367430A1 (de)
RU (1) RU2004106530A (de)
WO (1) WO2003014063A2 (de)
ZA (1) ZA200401727B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE41990E1 (en) 1996-12-03 2010-12-07 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6867305B2 (en) 1996-12-03 2005-03-15 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
WO2003029195A1 (fr) 2001-09-28 2003-04-10 Sumika Fine Chemicals Co., Ltd. Intermediaires pour l'elaboration d'un derive de l'epothilone, et leur procede de production
DE10326195A1 (de) * 2003-06-07 2004-12-23 Schering Ag Geschützte 5,7-Dihydroxy-4,4-dimethyl-3-oxoheptansäureester und 5,7-Dihydroxy-2-alkyl-4,4-dimethyl-3-oxoheptansäureester für die Synthese von Epothilonen- und Derivaten und Verfahren zur Herstellung dieser Ester
CN110857276B (zh) * 2018-08-22 2021-03-02 中国科学院化学研究所 一类手性β-羟基酰胺类化合物及其制备方法与应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000058254A1 (en) * 1999-03-29 2000-10-05 The University Of Kansas Synthesis of epothilones

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4824980A (en) * 1988-09-02 1989-04-25 Dow Corning Corporation Process to produce O-silyl O,N-ketene acetals

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000058254A1 (en) * 1999-03-29 2000-10-05 The University Of Kansas Synthesis of epothilones

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
A. FÜRSTNER ET AL.: "Concise total synthesis of epothilone A and C based on alkyne metathesis", CHEM. COMMUN., 2001, pages 1057 - 9, XP002227326 *
J. MULZER ET AL.: "Total Synthesis of Epothilones B and D", J. ORG. CHEM., vol. 65, no. 22, 2000, pages 7456 - 67, XP002218886 *
R. E. TAYLOR, YUE CHEN: "Total Synthesis of Epothilones B and D", ORGANIC LETTERS, vol. 3, no. 14, 2001, pages 2221 - 4, XP002227325 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE41990E1 (en) 1996-12-03 2010-12-07 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof

Also Published As

Publication number Publication date
NO20040912L (no) 2004-03-02
CN1538952A (zh) 2004-10-20
EP1412322A2 (de) 2004-04-28
WO2003014063A2 (de) 2003-02-20
PL367430A1 (en) 2005-02-21
AR036207A1 (es) 2004-08-18
DE10138348A1 (de) 2003-02-27
CN1807403A (zh) 2006-07-26
BR0211649A (pt) 2004-07-13
IL160159A0 (en) 2004-07-25
JP2004537589A (ja) 2004-12-16
MXPA04000954A (es) 2004-04-20
RU2004106530A (ru) 2005-07-27
KR20040029394A (ko) 2004-04-06
PE20030345A1 (es) 2003-04-10
CA2456255A1 (en) 2003-02-20
ZA200401727B (en) 2005-04-12

Similar Documents

Publication Publication Date Title
AU2002213248A1 (en) Synthesis of epothilones and relates analogs
HK1070350A1 (en) Protected 3.5-dihydroxy-2.2-dimethyl-valeronitriles for the synthesis of epothilones and derivatives and method for the production and use thereof
AU3771100A (en) Synthesis of epothilones
AU2003233010A8 (en) Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
HK1067129A1 (en) A process for the preparation of perindopril, its analgous compounds and salts thereof using 2,5-dioxo-oxazolidine intermediate compounds
EP1380564A4 (de) Binaphtolderivate und verfahren zu dessen herstellung
AU2001269063A1 (en) Shortened synthesis of 3,3-diarylpropylamine derivatives
AU2002333336A1 (en) Protected 3.5-dihydroxy -2.2-dimethyl-valeronitriles for the synthesis of epothilones and derivatives and method for the production and use thereof
WO2003014063A3 (de) Geschützte 3,5-dihydroxy-2,2-dimethyl-valeroamide für die synthese von epothilonen und derivaten und verfarhen zur herstellung und die verwendung
WO2005037780A3 (de) Amidomethyl-substituierte 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromen-6-yl-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
AU2002241211A1 (en) Imidazo-triazine derivatives as pde 5 inhibitors
HK1078853A1 (en) A new process for the preparation of epothilone derivatives
AU2002340805A1 (en) Protected 3.5-dihydroxy-2.2-dimethyl-valeroamides for the synthesis of epothilone and derivatives and method for the production and use thereof
EP1243564A3 (de) Verfahren zur Verhinderung von Ablagerungen
IL162770A (en) Process for the preparation of 7??-methyl-estr-4-ene-3-one derivatives
PL360544A1 (en) Thiazole derivatives of 2-methoxyimino-2-(pyridinyloxymethyl)-phenyl-acetamides useful as fungicides
WO2003004464A3 (de) Heterozyklische amidderivate und deren verwendung als schädlingsbekämpfungsmittel
AU4291901A (en) Process for the production of 2-hydroxyethylmaleimide and the product obtained by the process
EP1306368A3 (de) 3,4-Dihydro-1H-Naphthalin-Derivate als hoch selektive Cyclooxygenase-2-Inhibitoren
WO2003045909A3 (en) Methods and intermediates for the synthesis of azepines
GB0202396D0 (en) Production of delta 9 tetrahydrocannabinol
AU2001262240A1 (en) Process for the production of 2,2,6-trimethylcyclohexane-1,4-dione
AU2002218058A1 (en) Three-dimensionally shaped object comprised of a compound material, a component part or functional part included therewith, and a method for the production thereof
AU2002312109A1 (en) Process for the production of nylon 6
AU2001277662A1 (en) A process for the synthesis of atorvastatin form v and phenylboronates as intermediate compounds

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DK DZ EC EE ES FI GB GD GE GH GM HR ID IL IN IS JP KE KG KP KR KZ LC LK LS LT LU LV MA MD MG MK MN MW MZ NO NZ OM PH PL PT RO RU SD SE SI SK SL TJ TM TN TR TT TZ UA UG VN YU ZA ZM

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2002774500

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: PA/a/2004/000954

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 20028152379

Country of ref document: CN

Ref document number: 160159

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2456255

Country of ref document: CA

Ref document number: 2003519015

Country of ref document: JP

Ref document number: 1020047001710

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 467/DELNP/2004

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 200401721

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: 2002340805

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2002774500

Country of ref document: EP